EQS-News: Epigenomics AG / Key word: Personnel
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
15.02.2024 / 10:00...
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Epigenomics AG: Supervisory Board of Epigenomics AG appoi...
EQS-News: Epigenomics AG / Key word: Personnel
Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet
26.01.2024 / 13:16 CET/CEST
The issuer is...
EQS-News: Epigenomics AG / Key word: Half Year Report/Half Year Results
Epigenomics AG publishes financial results for the first six months 2023
10.08.2023 /... -Today at 02:02 am- MarketScreener
Press Release Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin and San Diego, CA , May 31, 2023 - Epigenomics... | May 31, 2023
31.05.2023 - EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results Epigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of ... Seite 1
EQS-News: Epigenomics AG / Key word: Quarterly / Interim Statement/Quarter Results
Epigenomics AG Reports Financial Results for the First... | May 31, 2023
Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced
/PRNewswire/ -- Immunovia AB (publ) ("Immunovia") published the notice to the Annual General Meeting 2023 on 25 April 2023 together with the Nomination...